We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Diagnostic Chip Targets Multidrug Resistant Tuberculosis

By LabMedica International staff writers
Posted on 29 Nov 2012
Print article
A multiplexed molecular diagnostic chip is capable of fast and accurate detection of Mycobacterium Tuberculosis Complex (MTBC) and its mutations, as well as nine other clinically important nontubercular Mycobacteria.

The newly launched Lab-on-Chip platform, marketed by Veredus Laboratories (Singapore) as the VerePLEX biosystem, combines Micro-Electro-Mechanical-Systems (MEMS) with microfluidics, to integrate multiplexed DNA amplification with microarray detection for rapid, cost-effective, and accurate analysis of biological materials.

The mutations in M. tuberculosis are responsible for its resistance to multiple drugs and for the global spread of Tuberculosis (TB). The rise of multidrug-resistant TB is a global healthcare challenge. Effective treatment of TB involves accurate and fast diagnosis followed by a strict regimen of the appropriate drugs. Shortcomings in this treatment can cause the TB organism to mutate into drug-resistant strains that can become increasingly difficult and expensive to treat.

Conventional methods of accurately identifying TB infections can take up to 8 weeks. In contrast, VereMTB can complete the diagnosis and identify the specific Mycobacterium causing the infection and drug resistance in less than 3 hours from natural samples, avoiding the need for culturing, the most time-consuming part of the traditional method. Additionally due to its compact size, the system can be deployed in a wide range of settings at point-of-need. “Natural samples” refer to direct sputum coughed out by TB patients.

The VereMTB chip is currently undergoing evaluations by the Chinese Center for Disease Control and Prevention (Beijing, China) as part of their ongoing program to assess new technologies for TB diagnostics. According to the 2012 World Health Organization report on TB, India and China combined have almost 40% of the world’s TB cases. Nearly 60% of multidrug resistant cases in 2011 were found in India, China, and the Russian Federation.

Related Links:

Veredus Laboratories


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Human Insulin CLIA
Human Insulin CLIA Kit
New
Silver Member
Oncology Molecular Diagnostic Test
BCR-ABL Dx ELITe MGB Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Molecular Diagnostics

view channel
Image: This medium is used to grow malaria parasites (Photo courtesy of Kyle Dykes/UC San Diego Health Sciences)

New Approach to Help Predict Drug Resistance in Malaria and Infectious Diseases

Malaria, a disease transmitted by mosquitoes that affects millions worldwide, remains a significant public health concern, especially in tropical and subtropical regions. Despite significant efforts to... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.